Neovacs’ Second Kinoid enters clinical testing
Initiation of Phase I/II study of IFNalpha Kinoid in lupus patients
09-Apr-2010 -
Neovacs announced that it has initiated a Phase I/II study of its Interferon alpha (IFNalpha) Kinoid in lupus patients. Regulatory and ethics committee approvals for the trial have been received in France and Belgium, and further approvals are being sought in a number of other European countries. ...
Belgium
dosing
rheumatology